Finance

Beta
Lists
301108:SHE
Tongling Jieya Biologic Technolgy Co Ltd
CN¥22.48
+1.12%
(+0.25) 1D
Jun 5, 3:04:40 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301108...
Open
CN¥22.23
High
CN¥22.77
Low
CN¥21.92
Mkt. cap
2.50B
Avg. vol.
1.73M
Volume
1.37M
Dividend
1.11%
Quarterly dividend
CN¥0.06
Ex-dividend date
May 20, 2026
P/E ratio
32.81
52-wk high
CN¥39.43
52-wk low
CN¥21.91
EPS
CN¥0.69
Shares outstanding
112.56M
No. of employees
634
Open
CN¥22.23
High
CN¥22.77
Low
CN¥21.92
Mkt. cap
2.50B
Avg. vol.
1.73M
Volume
1.37M
Dividend
1.11%
Quarterly dividend
CN¥0.06
Ex-dividend date
May 20, 2026
P/E ratio
32.81
52-wk high
CN¥39.43
52-wk low
CN¥21.91
EPS
CN¥0.69
Shares outstanding
112.56M
No. of employees
634
News stories
From sources across the web
About Tongling Jieya Biologic Technolgy Co Ltd
CEO-
Employees634
FoundedAug 31, 1999
Headquarters-
SectorPersonal care products
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
186.48M
254.65M
207.24M
192.21M
Cost of goods sold
139.38M
183.66M
162.61M
144.18M
Cost of revenue
139.38M
183.66M
162.61M
144.18M
Research and development expenses
5.73M
9.69M
7.35M
7.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.44M
22.01M
12.43M
23.39M
Operating expense
23.92M
38.06M
23.04M
30.92M
Total operating expenses
163.29M
221.72M
185.65M
175.10M
Operating income
23.19M
32.93M
21.59M
17.11M
Other non operating income
210.39K
-1.86M
-1.56M
-7.90M
EBT including unusual items
26.78M
41.01M
9.08M
10.03M
EBT excluding unusual items
25.89M
38.34M
17.10M
11.01M
Income tax expense
4.27M
5.52M
-282.08K
-238.79K
Effective tax rate
15.95%
13.47%
-3.11%
-2.38%
Other operating expenses
108.44K
3.90M
-3.12M
-1.87M
Net income
22.52M
35.32M
9.37M
10.27M
Net profit margin
12.08%
13.87%
4.52%
5.34%
Earnings per share
-
-
-
-
Interest and investment income
3.23M
7.31M
5.23M
3.24M
Interest expense
-
-771.41K
-621.53K
-1.44M
Net interest expenses
3.23M
6.54M
4.60M
1.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
33.26M
43.93M
31.91M
27.43M
Gain or loss from assets sale
-167.70K
167.70K
-360.92K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more